Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,078 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D, Baumann R, Krockenberger K, Vonthein R, Schreiber A, Boicev A, Würschmidt F, Weinstrauch E, Eilf K, Andreas P, Höller U, Dinges S, Piefel K, Zimmer J, Dellas K, Dunst J. Krug D, et al. Among authors: schreiber a. Strahlenther Onkol. 2021 Jan;197(1):48-55. doi: 10.1007/s00066-020-01689-7. Epub 2020 Oct 1. Strahlenther Onkol. 2021. PMID: 33001241 Free PMC article. Clinical Trial.
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial.
Krug D, Vonthein R, Schreiber A, Boicev AD, Zimmer J, Laubach R, Weidner N, Dinges S, Hipp M, Schneider R, Weinstrauch E, Martin T, Hörner-Rieber J, Olbrich D, Illen A, Heßler N, König IR, Dellas K, Dunst J. Krug D, et al. Among authors: schreiber a. Strahlenther Onkol. 2021 Sep;197(9):802-811. doi: 10.1007/s00066-020-01730-9. Epub 2020 Dec 15. Strahlenther Onkol. 2021. PMID: 33320286 Free PMC article. Clinical Trial.
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Pfaffendorf C, Vonthein R, Krockenberger-Ziegler K, Dellas K, Schreiber A, Uhlemann D, Dinges S, Würschmidt F, Andreas P, Weinstrauch E, Eilf K, Rades D, Höller U, Combs SE, Kazmierczak R, Fehlauer F, Schreck U, Zimmer J, Dunst J, Krug D. Pfaffendorf C, et al. Among authors: schreiber a. Breast. 2022 Aug;64:136-142. doi: 10.1016/j.breast.2022.05.008. Epub 2022 Jun 2. Breast. 2022. PMID: 35691249 Free PMC article. Clinical Trial.
Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study.
Kuhnt T, Schreiber A, Pirnasch A, Hautmann MG, Hass P, Sieker FP, Engenhart-Cabillic R, Richter M, Dellas K, Dunst J. Kuhnt T, et al. Among authors: schreiber a. Strahlenther Onkol. 2017 Sep;193(9):733-741. doi: 10.1007/s00066-017-1145-6. Epub 2017 May 12. Strahlenther Onkol. 2017. PMID: 28500491 Clinical Trial. English.
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Krause M, Stenbygaard L, Mjaaland I, Schreiber A, Kasti UM, Overgaard J; Danish Breast Cancer Group Radiation Therapy Committee. Offersen BV, et al. Among authors: schreiber a. J Clin Oncol. 2020 Nov 1;38(31):3615-3625. doi: 10.1200/JCO.20.01363. Epub 2020 Sep 10. J Clin Oncol. 2020. PMID: 32910709 Clinical Trial.
GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trial.
Soliman M, Yaromina A, Appold S, Zips D, Reiffenstuhl C, Schreiber A, Thames HD, Krause M, Baumann M. Soliman M, et al. Among authors: schreiber a. Radiother Oncol. 2013 Mar;106(3):299-304. doi: 10.1016/j.radonc.2012.12.008. Epub 2013 Jan 17. Radiother Oncol. 2013. PMID: 23333018 Clinical Trial.
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1.
Francolini G, Thomsen MS, Yates ES, Kirkove C, Jensen I, Blix ES, Kamby C, Nielsen MH, Krause M, Berg M, Mjaaland I, Schreiber A, Kasti UM, Boye K, Offersen BV. Francolini G, et al. Among authors: schreiber a. Radiother Oncol. 2017 May;123(2):282-287. doi: 10.1016/j.radonc.2017.03.011. Epub 2017 Mar 25. Radiother Oncol. 2017. PMID: 28351523 Clinical Trial.
Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01).
Rades D, Šegedin B, Conde-Moreno AJ, Garcia R, Perpar A, Metz M, Badakhshi H, Schreiber A, Nitsche M, Hipp P, Schulze W, Adamietz IA, Norkus D, Rudat V, Cacicedo J, Schild SE. Rades D, et al. Among authors: schreiber a. J Clin Oncol. 2016 Feb 20;34(6):597-602. doi: 10.1200/JCO.2015.64.0862. Epub 2016 Jan 4. J Clin Oncol. 2016. PMID: 26729431 Clinical Trial.
1,078 results